Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Philpot

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Frontiers in Neuroanatomy|June 4, 2026
Selective enrichment of TCF4 in GABAergic neurons during postnatal primate developmentAlain C Burette, Rebecca I Hipp, Sarah Salvador, et al.
Behavioural Brain Research|January 9, 2013
Behavioral deficits in an Angelman syndrome model: effects of genetic background and ageHsien-Sung Huang, Andrew J Burns, Randal J Nonneman, et al.
Elife|May 10, 2022
Rescue of behavioral and electrophysiological phenotypes in a Pitt-Hopkins syndrome mouse model by genetic restoration of <i>Tcf4</i> expressionHyojin Kim, Eric B Gao, Adam Draper, et al.
JCI Insight|February 3, 2026
A dual-reporter mouse for therapeutic discovery in Angelman syndromeHanna Vihma, Lucas M James, Hannah C Nourie, et al.
Plos One|May 27, 2014
Snx14 regulates neuronal excitability, promotes synaptic transmission, and is imprinted in the brain of miceHsien-Sung Huang, Bong-June Yoon, Sherian Brooks, et al.
Annals of the Child Neurology Society|August 26, 2025
Increased Extra-Axial Cerebrospinal Fluid Volume in Children with Angelman Syndrome: Links to Sleep Problems and SeizuresZumin Chen, Dea Garic, Yinuo Xu, et al.
The Journal of Clinical Investigation|October 21, 2015
Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome modelCaroline F Bruinsma, Martijn Schonewille, Zhenyu Gao, et al.
Journal of Medicinal Chemistry|May 8, 2026
Toward a Small Molecule Therapy for Angelman Syndrome: Structure-Activity Relationship Studies of 3-Aminopyrazole Phenylacetamides as Paternal <i>Ube3a</i> UnsilencersAnna Welton-Arndt, Hannah C Nourie, Hanna Vihma, et al.
Nature Neuroscience|February 8, 2011
NR3A-containing NMDARs promote neurotransmitter release and spike timing-dependent plasticityRylan S Larsen, Rebekah J Corlew, Maile A Henson, et al.
The Journal of Clinical Investigation|November 13, 2012
Pathway-specific dopaminergic deficits in a mouse model of Angelman syndromeThorfinn T Riday, Elyse C Dankoski, Michael C Krouse, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Frontiers in Neuroanatomy|June 4, 2026
Selective enrichment of TCF4 in GABAergic neurons during postnatal primate developmentAlain C Burette, Rebecca I Hipp, Sarah Salvador, et al.
Behavioural Brain Research|January 9, 2013
Behavioral deficits in an Angelman syndrome model: effects of genetic background and ageHsien-Sung Huang, Andrew J Burns, Randal J Nonneman, et al.
Elife|May 10, 2022
Rescue of behavioral and electrophysiological phenotypes in a Pitt-Hopkins syndrome mouse model by genetic restoration of <i>Tcf4</i> expressionHyojin Kim, Eric B Gao, Adam Draper, et al.
JCI Insight|February 3, 2026
A dual-reporter mouse for therapeutic discovery in Angelman syndromeHanna Vihma, Lucas M James, Hannah C Nourie, et al.
Plos One|May 27, 2014
Snx14 regulates neuronal excitability, promotes synaptic transmission, and is imprinted in the brain of miceHsien-Sung Huang, Bong-June Yoon, Sherian Brooks, et al.
Annals of the Child Neurology Society|August 26, 2025
Increased Extra-Axial Cerebrospinal Fluid Volume in Children with Angelman Syndrome: Links to Sleep Problems and SeizuresZumin Chen, Dea Garic, Yinuo Xu, et al.
The Journal of Clinical Investigation|October 21, 2015
Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome modelCaroline F Bruinsma, Martijn Schonewille, Zhenyu Gao, et al.
Journal of Medicinal Chemistry|May 8, 2026
Toward a Small Molecule Therapy for Angelman Syndrome: Structure-Activity Relationship Studies of 3-Aminopyrazole Phenylacetamides as Paternal <i>Ube3a</i> UnsilencersAnna Welton-Arndt, Hannah C Nourie, Hanna Vihma, et al.
Nature Neuroscience|February 8, 2011
NR3A-containing NMDARs promote neurotransmitter release and spike timing-dependent plasticityRylan S Larsen, Rebekah J Corlew, Maile A Henson, et al.
The Journal of Clinical Investigation|November 13, 2012
Pathway-specific dopaminergic deficits in a mouse model of Angelman syndromeThorfinn T Riday, Elyse C Dankoski, Michael C Krouse, et al.
Pageof 14